Transforming Healthcare
Through Regenerative Medicine

Services

For Large Pharmaceutical, Medical Device, and Biotech Companies:

  • Quarterly briefings and analytical support for senior executives to closely monitor key scientific, legal, regulatory, and business developments in the RM field;
  • Business strategy, investment, product development, in- and out-licensing, and strategic partnerships;
  • Due diligence for technology, IP, and/or company acquisitions;
  • M&A buy-side services to maintain anonymity and realize the best purchase price.

For Emerging Regenerative Medicine Companies:

  • Identify key business and scientific milestones necessary to achieve successive rounds of financing;
  • Create winning business plans and commercialization strategies.

For Non-Profit Clients and Government Organizations:

  • Business, financing and commercialization strategy workshops for grantees;
  • Business due diligence to compliment internal scientific expertise; and
  • Diversification strategies and ongoing project management of portfolio investments and grants.